p38 kinase inhibitors (Astex)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namep38 kinase inhibitors (Astex)
Drug Alias Namerheumatoid arthritis therapy (Astex)p38 kinase inhibitors (Astex)AT-1731AT-2796AT-2037 +[7] 
ClassificationSmall molecules
Mechanisms of ActionP38 α mitogen-activated protein kinase inhibitors
TargetsP38 α mitogen-activated protein kinase
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAstex Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstex Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A